about
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple scle...
Read More
0.54
-0.06
(-10.00%)
697.5K
XNAS Volume
XNAS 25 Sep, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
FibroBiologics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..